Surgical treatment of atrial septal defect in a patient with familial antithrombin-III deficiency

2Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Purpose: A 41-year-old woman with familial antithrombin-III deficiency was admitted to our hospital for patch closure of an atrial septal defect. Antithrombin-III activity was 43% and its antigen level was 12.2 mg/dl, was diagnosed so type I antithrombin-IIIdeficiency was diagnosed. Methods: A dose of 2500 U of antithrombin-III concentrate was administered at 1 day before surgery, 1 hour before surgery, and 1 day after surgery. Heparinazation was performed at 200 IU/kg and the activated clotting time increased from a baseline of 140s to 622s. After establishing cardiopulmonary bypass and cardioplegic arrest, closure of the septal defect was done with a pericardial patch. Results: The activated clotting time was maintained at more than 400s during cardiopulmonary bypass. There were no intraoperative complications and the postoperative course was uneventful. Conclusion: In patients with familial antithrombin-III deficiency, administration of antithrombin-III concentrate is effective when cardiopulmonary bypass is required. © 2012 The Editorial Committee of Annals of Thoracic and Cardiovascular Surgery. All rights reserved.

Cite

CITATION STYLE

APA

Hattori, T., Hata, M., Sezai, A., Wakui, S., & Shiono, M. (2013). Surgical treatment of atrial septal defect in a patient with familial antithrombin-III deficiency. Annals of Thoracic and Cardiovascular Surgery, 19(4), 323–325. https://doi.org/10.5761/atcs.cr.12.01981

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free